Moossavi S, Fehr K, Maleki H, Seyedpour S, Keshavarz-Fathi M, Tabasi F, Heravi M, Sharifian R, Shafiei G, Badihian N, Kelishadi R, Nematollahi S, Almasi M, Popescu S, Keshavarz-Fathi M, Rezaei N
Adv Exp Med Biol 1318 (-) 575-604 [2021-05-12; online 2021-05-12]
The disease 2019 (COVID-19) made a public health emergency in early 2020. Despite attempts for the development of therapeutic modalities, there is no effective treatment yet. Therefore, preventive measures in various settings could help reduce the burden of disease. In this chapter, the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing COVID-19, non-pharmaceutical approaches at individual and population level, chemoprevention, immunoprevention, preventive measures in different healthcare settings and other professions, special considerations in high-risk groups, and the role of organizations to hamper the psychosocial effects will be discussed.
PubMed 33973200
DOI 10.1007/978-3-030-63761-3_32
Crossref 10.1007/978-3-030-63761-3_32